Description: 

The purpose of this multidisciplinary aortic disease case conference is to strengthen clinician knowledge and clinical decision-making through the collaborative review of complex aortic pathology. By integrating expertise from cardiology, cardiovascular surgery, radiology, and vascular medicine, participants will analyze real-world cases and apply evidence-based strategies to enhance diagnostic accuracy, optimize procedural planning, and improve patient outcomes.

Target Audience: 

Nurse Practitioner (NP)

Nurse, Registered (RN)

Physicians (MD or DO)

Physician Assistant (PA)

Learning Objectives: 

After Attending This Activity Learners Should Be Able To:

1.Present and critically analyze recent complex aortic cases in a multidisciplinary forum

2.Interpret and integrate diagnostic findings and advanced imaging to accurately assess aortic pathology

3.Evaluate and compare evidence-based treatment options and management strategies for each case

4.Identify and implement opportunities for coordinated multidisciplinary care and longitudinal follow-up planning

5. Apply foundational and advanced principles of aortopathy through targeted didactic education.

Providing Culturally Appropriate Care which is Free of Implicit Biases (AB 1195 & 241):

Learners are strongly encouraged to engage in self-directed learning related to the impact of implicit biases in this clinical area via the references provided below:

• • Social Determinants of Health (SDOH)/Cultural or Linguistic Considerations:
    • Relation of Community-Level Socioeconomic Status to Delayed Diagnosis of Acute Type A Aortic Dissection” Lim, B et al May 1, 2022 AJC: https://www.ajconline.org/article/S0002-9149(22)00090-X/abstract
    • “Race and Socioeconomic Disparities in Proximal Aortic Surgery” Newell et al. ATS April 2024 https://www.annalsthoracicsurgery.org/article/s0003-4975%2823%2900360-0/fulltext

Disclosure of Financial or In-Kind Commercial Support & Conflict of Interest

Kim Newlin, Planner

Kim Newlin has disclosed a financial relationship with an ineligible company. She has served as a speaker for Boehringer-Ingelheim on a non-branded topic related to Transitions of Care and Chronic Kidney Disease. This financial relationship is not relevant to the content of this educational activity, and therefore no mitigation is required.

Dirk Baumann, Speaker
Dr. Baumann disclosed a relevant financial relationship as a consultant for Becton, Dickinson and Company. This relevant financial relationship was mitigated through independent oversight of the educational activity. Cases are selected by a multidisciplinary committee, and clinical discussions and treatment recommendations are made collectively with  peer-informed perspectives to ensure content remains evidence-based, balanced, and free of commercial bias.

Bilal Shafi, Speaker
Dr. Shafi disclosed relevant financial relationships as a consultant for Edwards Lifesciences and W. L. Gore & Associates, and as a scientific advisory board member for Aquedeon Medical. These relevant financial relationships were mitigated through independent oversight of the educational activity. Cases are selected by a multidisciplinary committee, and clinical discussions and treatment recommendations are made collectively with peer-informed perspectives to ensure content remains evidence-based, balanced, and free of commercial bias

No one else involved in the planning or presentation of this educational activity have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. No financial or in-kind commercial support was received to produce or promote this educational activity.   

– Provider Designee/Verification: Fozia Ferozali, Ed.D